Jennifer L Lund
Dados Biográficos
| ID | 113313 |
|---|---|
| NOME | Jennifer L Lund |
| PRENOMES | Jennifer L |
| SOBRENOME | Lund |
| ASSINATURA | LUND J L |
| AFILIAÇÕES | University of North Carolina at Chapel Hill |
| ORCID | 0000-0002-1108-0689 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 10 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 10 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2009 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Differences in the Measurement of Comorbidities Based on ICD-10-CM Coding Definitions Using Medicare Advantage Encounter Data and Fee-For-Service Claims
BACKGROUND: Medicare Advantage (MA) encounter data became available for research in 2019; data quality concerns remain. OBJECTIVES: We evaluated the consistency of ICD-10-CM comorbidity coding between MA and Fee-For-Service (FFS) data. METHODS: We used round 7 (2017) of the National Health and Aging Trends Study (NHATS) linked to Medicare enrollment, MA encounter, and FFS claims (2016-2017). We included participants continuously enrolled in MA or…
Investigating Disparities in Prescription Drug Use Among Mexican Americans and Non-Hispanic Whites
Claims-Based Measures of Care Coordination and Long-Term Health Among Older Women With Endometrial Cancer
BACKGROUND: Coordination of care between providers may help ensure that cancer survivors receive the appropriate health care services to improve their long-term health. We examined associations between a claims-based measure of care coordination and several health outcomes among older endometrial cancer survivors. METHODS: Using SEER-Medicare data, we identified women with endometrial cancer at ages 66+ during 2009-2015 (N=13,696). Medicare claim…
Pharmacist-facilitated Patient Reported Outcome Measure (PROM) monitoring
By presenting screenshots of our SmartForm©, our findings are useful to other healthcare systems looking for a PROM solution integrated in the EHR, with a reasonable pharmacist/clinician workload, and no requirement for patients to have internet access/comfort
Performance of a Claims-Based Frailty Proxy Using Varying Frailty Ascertainment Lookback Windows
BACKGROUND: Frailty is an aging-related syndrome of reduced physiological reserve to maintain homeostasis. The Faurot frailty index has been validated as a Medicare claims-based proxy for predicting frailty using billing information from a user-specified ascertainment window. OBJECTIVES: We assessed the validity of the Faurot frailty index as a predictor of the frailty phenotype and 1-year mortality using varying frailty ascertainment windows. RE…
“I am not considered much of a polygamist”
On July 6, 1884, Sarah Ann Peterson Lund attended Sunday worship services in the Ephraim, Utah, meetinghouse. Two visitors from southern Utah, St. George Temple president John D. T. McAllister and his assistant David H. Cannon, were the featured speakers. In a letter to her missionary husband, Sanie, as she was called, recounted the gist of their remarks, “they just gave the men fits for not going in to polygamy.” She then invoked a good-natured …
Comparison of Medicare Claims-based Proxy Measures of Poor Function and Associations With Treatment Receipt and Mortality in Older Colon Cancer Patients
BACKGROUND: Multiple claims-based proxy measures of poor function have been developed to address confounding in observational studies of drug effects in older adults. We evaluated agreement between these measures and their associations with treatment receipt and mortality in a cohort of older colon cancer patients. METHODS: Medicare beneficiaries age 66+ diagnosed with stage II-III colon cancer were identified in the Surveillance, Epidemiology, a…
Comparison of Seer Treatment Data With Medicare Claims
BACKGROUND: The population-based Surveillance, Epidemiology, and End Results (SEER) registries collect information on first-course treatment, including surgery, chemotherapy, radiation therapy, and hormone therapy. However, the SEER program does not release data on chemotherapy or hormone therapy due to uncertainties regarding data completeness. Activities are ongoing to investigate the opportunity to supplement SEER treatment data with other dat…
Identifying Specific Chemotherapeutic Agents in Medicare Data
BACKGROUND: Large health care databases are increasingly used to examine the dissemination and benefits and harms of chemotherapy treatment in routine practice, particularly among patients excluded from trials (eg, the elderly). Misclassification of chemotherapy could bias estimates of frequency and association, warranting an updated assessment. METHODS: We evaluated the validity of Medicare claims to identify receipt of chemotherapy and specific…
Inventory of Data Sources for Estimating Health Care Costs in the United States
OBJECTIVE: To develop an inventory of data sources for estimating health care costs in the United States and provide information to aid researchers in identifying appropriate data sources for their specific research questions. METHODS: We identified data sources for estimating health care costs using 3 approaches: (1) a review of the 18 articles included in this supplement, (2) an evaluation of websites of federal government agencies, non profit …
Sem obras proeminentes nesta página.
Inventory of Data Sources for Estimating Health Care Costs in the United States
OBJECTIVE: To develop an inventory of data sources for estimating health care costs in the United States and provide information to aid researchers in identifying appropriate data sources for their specific research questions. METHODS: We identified data sources for estimating health care costs using 3 approaches: (1) a review of the 18 articles included in this supplement, (2) an evaluation of websites of federal government agencies, non profit …
Identifying Specific Chemotherapeutic Agents in Medicare Data
BACKGROUND: Large health care databases are increasingly used to examine the dissemination and benefits and harms of chemotherapy treatment in routine practice, particularly among patients excluded from trials (eg, the elderly). Misclassification of chemotherapy could bias estimates of frequency and association, warranting an updated assessment. METHODS: We evaluated the validity of Medicare claims to identify receipt of chemotherapy and specific…
Comparison of Seer Treatment Data With Medicare Claims
BACKGROUND: The population-based Surveillance, Epidemiology, and End Results (SEER) registries collect information on first-course treatment, including surgery, chemotherapy, radiation therapy, and hormone therapy. However, the SEER program does not release data on chemotherapy or hormone therapy due to uncertainties regarding data completeness. Activities are ongoing to investigate the opportunity to supplement SEER treatment data with other dat…
Comparison of Medicare Claims-based Proxy Measures of Poor Function and Associations With Treatment Receipt and Mortality in Older Colon Cancer Patients
BACKGROUND: Multiple claims-based proxy measures of poor function have been developed to address confounding in observational studies of drug effects in older adults. We evaluated agreement between these measures and their associations with treatment receipt and mortality in a cohort of older colon cancer patients. METHODS: Medicare beneficiaries age 66+ diagnosed with stage II-III colon cancer were identified in the Surveillance, Epidemiology, a…
“I am not considered much of a polygamist”
On July 6, 1884, Sarah Ann Peterson Lund attended Sunday worship services in the Ephraim, Utah, meetinghouse. Two visitors from southern Utah, St. George Temple president John D. T. McAllister and his assistant David H. Cannon, were the featured speakers. In a letter to her missionary husband, Sanie, as she was called, recounted the gist of their remarks, “they just gave the men fits for not going in to polygamy.” She then invoked a good-natured …
Pharmacist-facilitated Patient Reported Outcome Measure (PROM) monitoring
By presenting screenshots of our SmartForm©, our findings are useful to other healthcare systems looking for a PROM solution integrated in the EHR, with a reasonable pharmacist/clinician workload, and no requirement for patients to have internet access/comfort
Performance of a Claims-Based Frailty Proxy Using Varying Frailty Ascertainment Lookback Windows
BACKGROUND: Frailty is an aging-related syndrome of reduced physiological reserve to maintain homeostasis. The Faurot frailty index has been validated as a Medicare claims-based proxy for predicting frailty using billing information from a user-specified ascertainment window. OBJECTIVES: We assessed the validity of the Faurot frailty index as a predictor of the frailty phenotype and 1-year mortality using varying frailty ascertainment windows. RE…
Investigating Disparities in Prescription Drug Use Among Mexican Americans and Non-Hispanic Whites
Claims-Based Measures of Care Coordination and Long-Term Health Among Older Women With Endometrial Cancer
BACKGROUND: Coordination of care between providers may help ensure that cancer survivors receive the appropriate health care services to improve their long-term health. We examined associations between a claims-based measure of care coordination and several health outcomes among older endometrial cancer survivors. METHODS: Using SEER-Medicare data, we identified women with endometrial cancer at ages 66+ during 2009-2015 (N=13,696). Medicare claim…
Differences in the Measurement of Comorbidities Based on ICD-10-CM Coding Definitions Using Medicare Advantage Encounter Data and Fee-For-Service Claims
BACKGROUND: Medicare Advantage (MA) encounter data became available for research in 2019; data quality concerns remain. OBJECTIVES: We evaluated the consistency of ICD-10-CM comorbidity coding between MA and Fee-For-Service (FFS) data. METHODS: We used round 7 (2017) of the National Health and Aging Trends Study (NHATS) linked to Medicare enrollment, MA encounter, and FFS claims (2016-2017). We included participants continuously enrolled in MA or…
Medicine (8 obras) · Internal Medicine (5 obras) · Internal Medicine (4 obras) · Cancer (3 obras) · Demography (3 obras) · Epidemiology (3 obras) · Global Cancer Incidence and Screening (3 obras) · Health Systems, Economic Evaluations, Quality of Life (3 obras) · Statistics (3 obras) · Advanced Causal Inference Techniques (2 obras)